Back to News
Market Impact: 0.1
UNCY URGENT DEADLINE: Unicycive Therapeutics, Inc. Investors Have Until November 2nd to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
Source: globenewswire.com
Legal & Litigation
Bragar Eagel & Squire litigation partner Brandon Walker encouraged investors who suffered losses in Unicycive Therapeutics (UNCY) to contact him to discuss their options. The headline provides no details on the alleged matter, investor losses, or any legal filing.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
More News
- Universal Health Services falls 3% on legal settlement concerns
- Meta’s $25 billion legal loss just put blood in the water
- Anthropic's IPO is risky business
- Japan internet giant GMO says hackers posted stolen customer data
- Newsom agrees smart glasses need privacy rules—just not the ones California lawmakers wrote
- Alibaba wins injunction against Pentagon contract restrictions tied to China blacklist